Tag Archives: MAP infection

June, 2016

  • 22 June

    RedHill Biopharma’s Crohn’s Disease Drug Shows Potential Efficacy in Trial

    TEL-AVIV, Israel, June 22, 2016 RedHill Biopharma Ltd. (NASDAQ: RDHL) (TASE: RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases and cancer, today announced the publication of an article demonstrating the potential …